BioCentury
ARTICLE | Top Story

TolerRx raises $35M; signs DNA deal

January 3, 2003 8:00 AM UTC

TolerRx (Cambridge, Mass.) raised $35 million in a series C round led by Skyline Ventures. Other investors included HealthCare Ventures; Rho Ventures; Vertex Management; Sprout Group; Artal Services; Genentech (DNA); Lehman Brothers Healthcare Fund; Yasuda Enterprise; Mizuho Capital; Aozora Investment; and Duke University. The company is developing antibodies to induce and maintain immunological tolerance and reprogram the immune system to treat patients with immune-related diseases. ...